CPRX - Catalyst Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$32.00
DETAILS
HIGH:
$32.00
LOW:
$32.00
MEDIAN:
$32.00
CONSENSUS:
$32.00
UPSIDE:
2.37%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Smith | 844,887 | $20.9M | 0.2% | -2,518,920 | DECREASED |
| Wood | 425,865 | $10.5M | 0.0% | +425,865 | NEW |
| Greenblatt | 61,371 | $1.5M | 0.0% | -594 | DECREASED |
| Cooperman | 40,542 | $1.0M | 0.0% | +29,762 | INCREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-02-17 | Russo Gregg | officer: Chief HR Officer | M-Exempt | 687 | -- | -- |
| 2026-02-17 | Russo Gregg | officer: Chief HR Officer | F-InKind | 211 | -- | -- |
| 2026-01-05 | Daly Richard J | director, officer: President and CEO | F-InKind | 10,577 | -- | -- |
| 2026-01-05 | Kalb Michael Wayne | officer: Executive Vice President & CFO | M-Exempt | 7,139 | -- | -- |
| 2026-01-05 | Kalb Michael Wayne | officer: Executive Vice President & CFO | F-InKind | 2,080 | -- | -- |
| 2026-01-05 | Daly Richard J | director, officer: President and CEO | M-Exempt | 42,105 | -- | -- |
| 2025-12-29 | DENKHAUS DONALD A | director | M-Exempt | 1,334 | -- | -- |
| 2025-12-29 | Elsbernd Brian | officer: Chief Compliance/Legal Officer | M-Exempt | 6,667 | -- | -- |
| 2025-12-29 | Elsbernd Brian | officer: Chief Compliance/Legal Officer | F-InKind | 2,623 | -- | -- |
| 2025-12-29 | Tierney David S | director | M-Exempt | 1,334 | -- | -- |
| 2025-12-29 | Sundaram Preethi | officer: Chief Strategy Officer | M-Exempt | 6,667 | -- | -- |
| 2025-12-29 | Sundaram Preethi | officer: Chief Strategy Officer | F-InKind | 2,369 | -- | -- |
| 2025-12-29 | Miller Steve | officer: Chief Op. & Scientific Officer | M-Exempt | 14,000 | -- | -- |
| 2025-12-29 | MCENANY PATRICK J | director, other: Chairman of Board of Directors | F-InKind | 6,786 | -- | -- |
| 2025-12-29 | MCENANY PATRICK J | director, other: Chairman of Board of Directors | M-Exempt | 26,334 | -- | -- |
| 2025-12-29 | Daly Richard J | director, officer: President and CEO | M-Exempt | 1,334 | -- | -- |
| 2025-12-29 | Daly Richard J | director, officer: President and CEO | F-InKind | 524 | -- | -- |
| 2025-12-29 | Del Carmen Jeffrey | officer: Chief Commercial Officer | M-Exempt | 8,667 | -- | -- |
| 2025-12-29 | Del Carmen Jeffrey | officer: Chief Commercial Officer | F-InKind | 3,839 | -- | -- |
| 2025-12-29 | Harper Molly | director | M-Exempt | 1,334 | -- | -- |
| 2025-12-12 | Harper Molly | director | SELL | 4,473 | $23.73 | $106K |
| 2025-12-12 | Harper Molly | director | SELL | 6,746 | $23.06 | $156K |
| 2025-12-12 | Harper Molly | director | M-Exempt | 20,000 | $5.78 | $116K |
| 2025-12-12 | Harper Molly | director | SELL | 15,527 | $23.20 | $360K |
| 2025-12-08 | Elsbernd Brian | officer: Chief Compliance/Legal Officer | M-Exempt | 7,067 | -- | -- |